Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David I Bernstein

Showing results (131-140 of 379) with videos related to

Pageof 38
Sort By:
Infection and Immunity|December 23, 2003
Antibody-mediated neutralization of pertussis toxin-induced mitogenicity of human peripheral blood mononuclear cellsScott H Millen, David I Bernstein, Beverly Connelly, et al.
Clinical and Vaccine Immunology : CVI|November 21, 2014
Safety and immunogenicity of escalating dosages of a single oral administration of peru-15 pCTB, a candidate live, attenuated vaccine against enterotoxigenic Escherichia coli and Vibrio choleraeWilbur H Chen, Jose Garza, Monique Choquette, et al.
Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association|September 18, 2007
Factors influencing pediatricians' intention to recommend human papillomavirus vaccinesJessica A Kahn, Susan L Rosenthal, Abbigail M Tissot, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 25, 2019
Usability of mepolizumab single-use prefilled syringe for patient self-administrationElisabeth H Bel, David I Bernstein, Leif Bjermer, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|July 31, 2007
Effective strategies for HPV vaccine delivery: the views of pediatriciansAbbigail M Tissot, Gregory D Zimet, Susan L Rosenthal, et al.
American Journal of Rhinology & Allergy|April 9, 2013
Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitisEli O Meltzer, David I Bernstein, Bruce M Prenner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2023
Safety and Immunogenicity of a monovalent inactivated influenza A/H5N8 virus vaccine given with and without AS03 or MF59 adjuvants in healthy adultsPatricia L Winokur, Theresa E Hegmann, Wendy A Keitel, et al.
Vaccine|November 16, 2004
Lack of induction of autoantibody responses following immunization with cytomegalovirus (CMV) glycoprotein B (gB) in healthy CMV-seronegative subjectsMark R Schleiss, David I Bernstein, Murray Passo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 16, 2023
Anaphylaxis in Clinical Trials of Sublingual Immunotherapy TabletsHendrik Nolte, Moisés A Calderon, David I Bernstein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 28, 2018
Treatment with the SQ house dust mite sublingual immunotherapy tablet may be initiated year-roundHendrik Nolte, David I Bernstein, Jörg Kleine-Tebbe, et al.
Pageof 38

Showing results (131-140 of 379) with videos related to

Sort By:
Pageof 38
Infection and Immunity|December 23, 2003
Antibody-mediated neutralization of pertussis toxin-induced mitogenicity of human peripheral blood mononuclear cellsScott H Millen, David I Bernstein, Beverly Connelly, et al.
Clinical and Vaccine Immunology : CVI|November 21, 2014
Safety and immunogenicity of escalating dosages of a single oral administration of peru-15 pCTB, a candidate live, attenuated vaccine against enterotoxigenic Escherichia coli and Vibrio choleraeWilbur H Chen, Jose Garza, Monique Choquette, et al.
Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association|September 18, 2007
Factors influencing pediatricians' intention to recommend human papillomavirus vaccinesJessica A Kahn, Susan L Rosenthal, Abbigail M Tissot, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 25, 2019
Usability of mepolizumab single-use prefilled syringe for patient self-administrationElisabeth H Bel, David I Bernstein, Leif Bjermer, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|July 31, 2007
Effective strategies for HPV vaccine delivery: the views of pediatriciansAbbigail M Tissot, Gregory D Zimet, Susan L Rosenthal, et al.
American Journal of Rhinology & Allergy|April 9, 2013
Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitisEli O Meltzer, David I Bernstein, Bruce M Prenner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2023
Safety and Immunogenicity of a monovalent inactivated influenza A/H5N8 virus vaccine given with and without AS03 or MF59 adjuvants in healthy adultsPatricia L Winokur, Theresa E Hegmann, Wendy A Keitel, et al.
Vaccine|November 16, 2004
Lack of induction of autoantibody responses following immunization with cytomegalovirus (CMV) glycoprotein B (gB) in healthy CMV-seronegative subjectsMark R Schleiss, David I Bernstein, Murray Passo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 16, 2023
Anaphylaxis in Clinical Trials of Sublingual Immunotherapy TabletsHendrik Nolte, Moisés A Calderon, David I Bernstein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 28, 2018
Treatment with the SQ house dust mite sublingual immunotherapy tablet may be initiated year-roundHendrik Nolte, David I Bernstein, Jörg Kleine-Tebbe, et al.
Pageof 38